Orphazyme Valuation
| ORPHA Stock | DKK 1,075 19.60 1.79% |
At this time, the company appears to be overvalued. Orphazyme AS holds a recent Real Value of kr944.77 per share. The prevailing price of the company is kr1074.8. Our model determines the value of Orphazyme AS from analyzing the company fundamentals such as Operating Margin of (15.38) %, return on equity of -4.87, and Shares Outstanding of 35.31 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Orphazyme's price fluctuation is very steady at this time. Calculation of the real value of Orphazyme AS is based on 3 months time horizon. Increasing Orphazyme's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Orphazyme AS is useful when determining the fair value of the Orphazyme stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Orphazyme. Since Orphazyme is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Orphazyme Stock. However, Orphazyme's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1074.8 | Real 944.77 | Hype 1074.8 | Naive 1041.77 |
The real value of Orphazyme Stock, also known as its intrinsic value, is the underlying worth of Orphazyme AS Company, which is reflected in its stock price. It is based on Orphazyme's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Orphazyme's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Orphazyme's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Orphazyme AS helps investors to forecast how Orphazyme stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Orphazyme more accurately as focusing exclusively on Orphazyme's fundamentals will not take into account other important factors: Orphazyme Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Orphazyme's current stock value. Our valuation model uses many indicators to compare Orphazyme value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orphazyme competition to find correlations between indicators driving Orphazyme's intrinsic value. More Info.Orphazyme AS is regarded fourth in price to book category among related companies. It is regarded fourth in price to sales category among related companies fabricating about 2.23 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Orphazyme by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Orphazyme's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orphazyme's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Orphazyme's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Orphazyme and how it compares across the competition.
About Orphazyme Valuation
The stock valuation mechanism determines the current worth of Orphazyme AS on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Orphazyme AS. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Orphazyme AS based exclusively on its fundamental and basic technical indicators. By analyzing Orphazyme's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Orphazyme's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orphazyme. We calculate exposure to Orphazyme's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orphazyme's related companies.Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.
8 Steps to conduct Orphazyme's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Orphazyme's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Orphazyme's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Orphazyme's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Orphazyme's revenue streams: Identify Orphazyme's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Orphazyme's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Orphazyme's growth potential: Evaluate Orphazyme's management, business model, and growth potential.
- Determine Orphazyme's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Orphazyme's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orphazyme AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Orphazyme AS information on this page should be used as a complementary analysis to other Orphazyme's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Orphazyme Stock analysis
When running Orphazyme's price analysis, check to measure Orphazyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orphazyme is operating at the current time. Most of Orphazyme's value examination focuses on studying past and present price action to predict the probability of Orphazyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orphazyme's price. Additionally, you may evaluate how the addition of Orphazyme to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |